Skip to main content
. 2022 Mar 7;12(3):36. doi: 10.1038/s41408-022-00631-7

Fig. 6. Tamoxifen decreases the incidence of DLBCL in BC patients.

Fig. 6

Odds ratio for patients treated with tamoxifen, aromatase inhibitors or no hormone therapy (HT), with 95% confidence intervals (CI) and P values.